Type 1 Diabetes 2017
Professional continuous glucose monitoring can significantly reduce the economic burden of type 2 diabetes.
Adapting open-loop settings that are used by the artificial pancreas algorithm is easily understandable and transparent to both patients and physicians.
Real-time continuous glucose monitoring systems are comparable to traditional blood glucose monitoring methods in preterm infants.
With this statement, researchers hope to improve safety and efficacy outcomes, advance technology, and improve patient quality of life and health outcomes.
Although the incidence of severe hypoglycemia has decreased while insulin pump use has increased, a causal relationship has not been established between insulin administration methods and risk of complications from diabetes.
Secure messaging presents an opportunity for patients and healthcare providers to collaborate on self-management issues like glycemic control, diet, and exercise.
Peptide immunotherapy may offer a personalized approach to modulating the immune response in persons with type 1 diabetes.
New monitoring system involves the placement of a small sensor wire beneath the skin surface to continuously monitor glucose levels.
Data from a phase 1 study was presented at the 2017 ADA Scientific Sessions.
Although metformin did not improve glycemic control in patients with type 1 diabetes, the treatment did improve cardiovascular disease risk management.
Both mealtime and postmeal faster insulin aspart are noninferior to mealtime conventional insulin aspart, regarding HbA1c change from baseline.
After 3 days without taking insulin, a patient presents to the emergency room with hyperglycemia and concerns of diabetic ketoacidosis.
There is a 5% probability of progression from state 1 to state 5 between retinal screenings.
Adjuvant metformin produced a small but nonsignificant decrease in body mass index and insulin dose, but by year 10, no beneficial effects were evident.
The studies will assess the safety, efficacy, and user-friendliness among other aspects, of multiple artificial pancreas devices.
Exercise management for patients with type 1 diabetes should be individualized, depending on insulin concentrations and exercise type/intensity.
Patients with type 1 diabetes who used multiple insulin injections daily experienced reductions in HbA1c with continuous glucose monitoring.
The use of hydrolyzed vs nonhydrolyzed cow's milk-based infant formula does not appear to reduce risk for islet autoimmunity.
People with type 1 diabetes have specific changes in gut bacteria and inflammation of the digestive tract compared with people without the disease.
A recent study confirms that frequent enterovirus infection may contribute to the development of type 1 diabetes in children.
Endocrinology Advisor Articles
- FDA Approves Admelog Short-Acting Insulin Lispro Injection
- Fertility Hormone Therapy and Cardiovascular Outcomes: What We Know
- Effects of Peer Influence in Adolescents With Type 1 Diabetes
- More Evidence That Saxagliptin Does Not Increase Risk for AMI in Diabetes
- One-Hour Glucose Readings Predict T2D Risk Better Than 2-Hour Measurements
- FDA: Vitamin B7 May Interfere With Lab Tests for Hormone Levels
- Injected and Oral Medications Equally Safe for Gestational Diabetes
- Adjunctive Dapagliflozin Improves Glycemic Control in T1D
- Estradiol Therapy May Benefit Overall Cognition in Postmenopausal Women
- Stopping Postmenopausal HT May Increase Risk for Cardiac, Stroke Death
- Psychosocial Benefits of a Bihormonal Bionic Pancreas System in T1D
- Safety of Chronic Total Occlusion Percutaneous Coronary Intervention in Diabetes
- Oral Insulin Not a Reliable Preventive Strategy for Type 1 Diabetes
- Prevention of Bone Mineral Density Loss Needed in Epilepsy
- Gastric Bypass Blunts B-Cell Sensitivity During Glycemia